本刊2020年第23卷第2期刊登的題為“中國非小細(xì)胞肺癌免疫檢查點(diǎn)抑制劑治療專家共識（2019年版）”[周彩存, 王潔, 步宏, 等. 中國非小細(xì)胞肺癌免疫檢查點(diǎn)抑制劑治療專家共識(2019年版). 中國肺癌雜志, 2020, 23(2): 65-76.] 一文中：第65頁作者單位中“400042 重慶，重慶大坪醫(yī)院（朱波）”應(yīng)改為“400037 重慶，重慶新橋醫(yī)院（朱波）”；第66頁第1部分第3行“年齡標(biāo)化率（age standardized rate, ASR）1.5/10萬和14.6/10萬”應(yīng)改為“年齡標(biāo)化率（age standardized rate, ASR）31.5/10萬和14.6/10萬”。特此更正。對此深表歉意。

Erratum: Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2019 version)

Zhou CC, Wang J, Bu H, et al.

Zhongguo Fei Ai Za Zhi, 2020, 23(2): 65-76.

In the version of this article initially published, error appeared on page 65. The author address should be“400037 重慶，重慶新橋醫(yī)院（朱波）”. And another error appeared on page 66.The first sentence in part 1 should be “年齡標(biāo)化率（age standardized rate, ASR）31.5/10萬和14.6/10萬”.